Johnson & JohnsonJNJ

• Phase ?루마테페론 감정 둔화 동반 우울증 부가치료 임상시작 전Lumateperone Added to Antidepressant Therapy in Adults With Major Depressive Disorder Experiencing Emotional Blunting
  34%
• Phase 2TP53 변이 만성림프구성백혈병 엡코리타맙 3제 병용 임상시작 전Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations
  70%
• Phase 3다발골수종 환자 맞춤형 치료 전략 연구모집 중Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level
  57%
• Phase ?조울증 우울기 환자 루마테페론의 비만·노화 개선 연구시작 전The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression
  52%
• Phase ?중증 심부전 폐울혈 완화를 위한 션트 삽입 임상시작 전RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EF
  59%
• Phase 2다발골수종 환자 대상 인플릭시맙의 면역 부작용 예방 임상모집 중Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma
  62%
• Phase ?심근경색 쇼크 환자 대상 초소형 혈류펌프 치료모집 중Rapid Microaxial Flow Pump Support and Escalation in Patients With Myocardial Infarction Associated Cardiogenic Shock and Persistent Need of Hemodynamic Support
  59%
• Phase 2다발골수종·아밀로이드증 테클리스타맙·다라투무맙 2상모집 중A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).
  56%
• Phase ?인공수정체 기울어짐 및 위치 이탈 정밀 평가모집 중Objective Assessment of Intraocular Lens Tilt and Decentration
  59%
• Phase ?건선성 관절염 환자 대상 구셀쿠맙 피하주사 임상모집 중A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)
  64%
• Phase ?빛 산란이 시각 기능에 미치는 영향 평가 연구모집 중Evaluation of Effect of Scatter on Visual Performance
  59%

성공 확률은 BERA의 AI 모델(임상 설계·약물 구조·과거 사례 기반)이 계산한 값이에요. 실제 결과와 다를 수 있어요. 예측이 없는 임상 9건은 생략했어요.